Suppliers / Allergan Sales

Allergan Sales

United States 5 duplicate records merged Updated 9 July 2026

Allergan Sales is an API and finished-dose manufacturer based in United States. It appears in 45 regulatory filings across 7 regulators, without an active US DMF or CEP on file. Its filings concentrate with DIGEMAPS (DO), EDE (AE) and ARCSA (EC). Its GMP standing is certified by MFDS (Korea), US FDA and ANVISA (Brazil). Its most recent recorded inspection, by US FDA, closed on 3 September 2024 as NAI.

0
active US DMFs
0
valid CEPs
6
registered plants 4 with an FDA FEI number
45
filings across 7 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
4 of 4 confirmed
Inspections
8 of 8 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 3 September 2024 NAI US FDA
  • 28 July 2023 NAI US FDA
  • 24 March 2022 NAI US FDA
  • 24 June 2021 VAI US FDA
  • 29 July 2019 VAI US FDA
  • 27 February 2019 VAI US FDA
  • 1 February 2017 NAI US FDA
  • 28 October 2016 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Texas 76712, United Arab Emirates Not on file
WACO, United States Not on file
Cincinnati, United States 1523957
Irvine, United States 2011068
Waco, United States 1643525
Campbell, United States 3000720089

Filings and GMP by regulator

Regulator Filings GMP certificates
DIGEMAPS (DO) 24 None
EDE (AE) 12 None
ARCSA (EC) 4 None
NPRA (MY) 2 None
INVIMA (CO) 1 None
MINSA (CR) 1 None
MFDS (Korea) None 2
US FDA None 2
ANVISA (Brazil) None 1

Questions about Allergan Sales

Does Allergan Sales hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Allergan Sales. It does have 45 filings with 7 regulators, so it is registered, just not with the two strong registers buyers usually screen on.
Is Allergan Sales FDA-registered?
4 sites operated by Allergan Sales carry an FDA establishment identifier (FEI), which means they are registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Allergan Sales's last inspection go?
The most recent inspection on record closed on 3 September 2024 as NAI (No Action Indicated: nothing objectionable was found). 8 inspections are on file.
Where does Allergan Sales manufacture?
6 registered sites are on record, in United Arab Emirates and United States (Texas 76712, Waco and Cincinnati among others). Every site is listed on this page with the register it came from.
What does Allergan Sales make?
1 molecule is on record against Allergan Sales, including Ketorolac. Each links through to that molecule's full manufacturer list.
Which regulators recognise Allergan Sales's GMP?
Current GMP certificates are on record from MFDS (Korea), US FDA and ANVISA (Brazil). GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Allergan Sales comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was NAI, on 3 September 2024.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates